Our discussion extends to the implications of SV2C’s role in synaptic vesicle trafficking, neurotransmitter release, and α-synuclein homeostasis, thereby laying the groundwork for future investigations that could pave the way for novel therapeutic strategies in combating PD. The gene discussed is SV2C; the disease is Parkinson disease.